Reveleer to Demonstrate AI’s Transformative Impact on Value-Based Care at ViVE 2025

Leading value-based care platform accelerates into 2025 with strong momentum and plans for continued growth.

GLENDALE, Calif., Feb. 13, 2025 /PRNewswire/ — Reveleer, the leading value-based care enablement platform, will demonstrate AI-powered, intelligent automation solutions at ViVE, taking place February 16-19, 2025.

Featuring its Evidence Validation Engine (EVE™), Reveleer’s platform unifies and transforms structured, semi-structured, and unstructured clinical data — such as notes, test results, and medical histories — into clinical insights. These insights intelligently automate and power workflows to improve efficiency, enhance patient care, and strengthen financial performance. By making sense of vast amounts of healthcare data, we help clinicians and health plans work together more effectively, keeping the focus where it belongs – delivering better patient care.

Reveleer solidified its leadership in artificial intelligence healthcare solutions in 2024 hitting significant milestones, including:

  • Processed 1.1 billion pages of clinical data helping payers and providers manage vast amounts of information with unparalleled efficiency.
  • Achieved an industry-leading accuracy rate of 99% through our proprietary AI-scoring model.
  • Facilitated the validation of over 2.5 million diagnoses showcasing its ability to use artificial intelligence to enhance clinical accuracy and scale.
  • Onboarded 25 new customers expanding its reach and impact across the healthcare ecosystem.

“Reveleer is transforming how payers and providers harness clinical data to drive better decisions and outcomes,” said Jay Ackerman, CEO of Reveleer. “Our AI-powered technology aggregates and analyzes patient data across care settings, delivering a complete, transparent view of the patient’s journey. More than just insights, our solutions take the next best action to intelligently automate and optimize value-based care workflows — driving efficiency, accuracy, and measurable ROI.”

ViVE attendees will have the opportunity to experience live demos of Reveleer’s risk, quality, and clinical intelligence solutions, and learn about how our intelligent automation optimizes workflows across the risk continuum.

To learn more about Reveleer, stop by booth 538 at ViVE 2025 or visit reveleer.com.

About Reveleer
As the industry’s pioneering value-based care (VBC) enablement platform, Reveleer is purpose-built to solve the most pressing real-world challenges faced by provider and health-plan organizations today. By unifying retrieval, clinical intelligence, risk adjustment, quality improvement, and member management solutions into one intelligent, AI powered system, Reveleer streamlines fragmented workflows to supercharge productivity, enhance care quality, and optimize performance on high-priority value-based initiatives. To learn more about Reveleer’s value-based care platform, visit us at Reveleer.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/reveleer-to-demonstrate-ais-transformative-impact-on-value-based-care-at-vive-2025-302375669.html

SOURCE Reveleer

Staff

Recent Posts

The UA Sprinkler Fitters Local 669 JATC – Notice of Privacy Incident

Landover, Maryland, February 6, 2026- The UA Sprinkler Fitters Local 669 Joint Apprenticeship and Training…

2 hours ago

Abbott Laboratories Announces Measurable Results From LATAM Diagnostic Market Development and Training Initiative Led by Claudia Marcela Riaño Caro

Regional program delivers double-digit sales growth, improved service performance, and expanded diagnostic access across Latin…

8 hours ago

GEARWRENCH Continues to Redefine Automotive Diagnostics with Powerful New Tools

Four new products available now to put full diagnostics in the palm of technician's handsSPARKS,…

8 hours ago

Tampa General’s Innovation Week Returns with New Programming to Showcase Breakthroughs in Patient Care and Technology

Global leaders, entrepreneurs and innovators will converge across the Tampa Medical & Research District and…

8 hours ago

New England Biolabs ® Proudly Partners with Automation Providers to Support NGS Library Prep Automation Globally

IPSWICH, Mass., Feb. 6, 2026 /PRNewswire/ -- New England Biolabs (NEB ®) will present several…

8 hours ago

Healthcare Triangle, Inc. Announces 1-for-60 Reverse Stock Split as Part of Nasdaq Compliance Plan

PLEASANTON, Calif., Feb. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"),…

14 hours ago